Stockreport

ProKidney Corp (PROK) Touts Reparencel Therapy for Growth [Yahoo! Finance]

ProKidney Corp. - Class A Ordinary Shares  (PROK) 
PDF Global Healthcare Conference, the company reiterated its focus on the promising cell therapy, Reparencel. ProKidney Corp (PROK) Touts Reparencel Therapy for Growth y [Read more]